Chiral Phosphoric Acids

Catalog No. Name CAS Inquiry
(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide
(11bS)​-2,​6-Bis([1,​1'-​biphenyl]​-​4-​yl)​-​8,​9,​10,​11,​12,​13,​14,​15-​octahydro-​4-​hydroxy-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin
(11bS)​-2,​6-Bis(4-​chlorophenyl)​-​4-​hydroxy-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin
(11bS)​-8,​9,​10,​11,​12,​13,​14,​15-​Octahydro-​4-​hydroxy-​2,​6-​bis(2,​4,​6-​trimethylphenyl)​-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin
(11bS)​-8,​9,​10,​11,​12,​13,​14,​15-​Octahydro-​4-​hydroxy-​2,​6-​bis(3,5-di-tert-butyl-4-methoxyphenyl)​-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin
(11bS)​-8,​9,​10,​11,​12,​13,​14,​15-​Octahydro-​4-​hydroxy-​2,​6-​bis(4-​methoxyphenyl)​-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin
(11bS)​-8,​9,​10,​11,​12,​13,​14,​15-​Octahydro-​4-​hydroxy-​2,​6-bis[3,5-bis[3,5-bis(trifluoromethyl)phenyl]phenyl]-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin
(11bS)​-8,​9,​10,​11,​12,​13,​14,​15-Octahydro-​4-​hydroxy-​2,​6-​bis(4-​nitrophenyl)​-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin
(11bS)​-8,​9,​10,​11,​12,​13,​14,​15-Octahydro-​4-​hydroxy-​2,​6-​bis[4-​(trifluoromethyl)​phenyl]​-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin
(11bS)​-8,​9,​10,​11,​12,​13,​14,​15-Octahydro-​4-​hydroxy-​2,​6-​di-​1-​pyrenyl-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin
(11bS)-2,6-Bis(3,5-dimethylphenyl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide
(11bS)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-2,6-Bis[3,5-bis(1,1-dimethylethyl)-4-methoxyphenyl]-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-2,6-Bis[4-(2-naphthalenyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-2,6-Bis[4-(tert-butyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-2,6-Di-1-pyrenyl-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
(11bS)-4-Oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
Chiral Technical Information
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.